NCT03657030View on ClinicalTrials.gov

Study of CVN424 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

64

Participants

Timeline

Start Date

September 18, 2018

Primary Completion Date

March 1, 2019

Study Completion Date

May 30, 2019

Conditions

Healthy

Interventions

DRUG

CVN424

SAD / MAD

DRUG

Placebo

Placebo

Trial Locations (1)

78744

PPD Development, LP, Austin

All Listed Sponsors

lead

Cerevance Beta, Inc.

INDUSTRY

NCT03657030 - Study of CVN424 in Healthy Subjects | Biotech Hunter | Biotech Hunter